Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Yenugonda VM"'
Publikováno v:
International Journal of Nanomedicine, Vol Volume 14, Pp 1937-1952 (2019)
Anubhab Mukherjee,1,2 Ariana K Waters,1,2 Pranav Kalyan,3 Achal Singh Achrol,2 Santosh Kesari,2 Venkata Mahidhar Yenugonda1,2 1Drug Discovery and Nanomedicine Research Program, 2Department of Translational Neurosciences and Neurotherapeutics, John Wa
Externí odkaz:
https://doaj.org/article/81f972ce6c44469f9b9de137c86ec48b
Autor:
Naeem A; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.; Health Research Governance Department, Ministry of Public Health, Doha, Qatar., Harish V; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC., Coste S; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC., Parasido EM; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC., Choudhry MU; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC., Kromer LF; Department of Neuroscience, Georgetown University Medical Center, Washington, DC., Ihemelandu C; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC., Petricoin EF; George Mason University, Center for Applied Proteomics and Molecular Medicine, Manassas, Virginia., Pierobon M; George Mason University, Center for Applied Proteomics and Molecular Medicine, Manassas, Virginia., Noon MS; Data Science Institute, University of Arizona, Texas, Arizona., Yenugonda VM; Department of Drug Discovery and Nanomedicine, Saint John's Cancer Institute, Santa Monica, California., Avantaggiati M; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC., Kupfer GM; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.; Department of Pediatrics, Georgetown University Medical Center, Washington, DC., Fricke S; Department of Radiology, Georgetown University Medical Center, Washington, DC.; Center for Translational Imaging, Georgetown University Medical Center, Washington, DC., Rodriguez O; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC.; Center for Translational Imaging, Georgetown University Medical Center, Washington, DC., Albanese C; Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC. albanese@georgetown.edu.; Department of Radiology, Georgetown University Medical Center, Washington, DC.; Center for Translational Imaging, Georgetown University Medical Center, Washington, DC.
Publikováno v:
Molecular cancer research : MCR [Mol Cancer Res] 2022 Jan; Vol. 20 (1), pp. 114-126. Date of Electronic Publication: 2021 Oct 11.
Autor:
Cheltsov A; Q-MOL LLC, San Diego, California, United States of America., Nomura N; John Wayne Cancer Institute and Pacific Neuroscience Institute at Providence Saint John's Health Center, Santa Monica, CA, USA., Yenugonda VM; John Wayne Cancer Institute and Pacific Neuroscience Institute at Providence Saint John's Health Center, Santa Monica, CA, USA., Roper J; Division of Gastroenterology, Department of Medicine, Duke University, Durham, North Carolina, 27710, USA., Mukthavaram R; Translational Neuro-Oncology Laboratories, Department of Neurosciences, University of California San Diego, La Jolla, CA, USA., Jiang P; Translational Neuro-Oncology Laboratories, Department of Neurosciences, University of California San Diego, La Jolla, CA, USA., Her NG; Korea Institute of Radiological and Medical Sciences, 75 Nowon-ro, Seoul, 01812, Korea., Babic I; John Wayne Cancer Institute and Pacific Neuroscience Institute at Providence Saint John's Health Center, Santa Monica, CA, USA., Kesari S; John Wayne Cancer Institute and Pacific Neuroscience Institute at Providence Saint John's Health Center, Santa Monica, CA, USA., Nurmemmedov E; John Wayne Cancer Institute and Pacific Neuroscience Institute at Providence Saint John's Health Center, Santa Monica, CA, USA. elmar.nurmammadov@providence.org.
Publikováno v:
Scientific reports [Sci Rep] 2020 May 15; Vol. 10 (1), pp. 8096. Date of Electronic Publication: 2020 May 15.
Publikováno v:
ACS chemical neuroscience [ACS Chem Neurosci] 2020 May 06; Vol. 11 (9), pp. 1218-1230. Date of Electronic Publication: 2020 Apr 29.
Autor:
Her NG; Korea Institute of Radiological & Medical Sciences, Nowon, Seoul 01812, Korea.; Samsung Medical Center, Gangnam, Seoul 06351, Korea., Babic I; John Wayne Cancer Institute & Pacific Neuroscience Institute, Providence Saint John's Health Center, Santa Monica, CA 90404, USA., Yenugonda VM; John Wayne Cancer Institute & Pacific Neuroscience Institute, Providence Saint John's Health Center, Santa Monica, CA 90404, USA., Kesari S; John Wayne Cancer Institute & Pacific Neuroscience Institute, Providence Saint John's Health Center, Santa Monica, CA 90404, USA., Nurmemmedov E; John Wayne Cancer Institute & Pacific Neuroscience Institute, Providence Saint John's Health Center, Santa Monica, CA 90404, USA.
Publikováno v:
BioTechniques [Biotechniques] 2020 Apr; Vol. 68 (4), pp. 180-184. Date of Electronic Publication: 2020 Feb 10.
Autor:
Yadavalli S, Yenugonda VM; John Wayne Cancer Institute & Pacific Neuroscience Institute at Providence Saint John's Health Center, Santa Monica, CA., Kesari S; John Wayne Cancer Institute & Pacific Neuroscience Institute at Providence Saint John's Health Center, Santa Monica, CA.
Publikováno v:
Cancer journal (Sudbury, Mass.) [Cancer J] 2019 Mar/Apr; Vol. 25 (2), pp. 139-146.
Autor:
Levin ED; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA. Electronic address: edlevin@duke.edu., Rezvani AH; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA., Wells C; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA., Slade S; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA., Yenugonda VM; Department of Translational Neurosciences and Neurotherapeutics, John Wayne Cancer Institute, 2200 Santa Monica Blvd, Santa Monica, CA 90404, USA., Liu Y; Drug Discovery Program and Georgetown University School of Medicine, Washington DC 20057, USA., Brown ML; Drug Discovery Program and Georgetown University School of Medicine, Washington DC 20057, USA., Xiao Y; Department of Pharmacology and Physiology, Georgetown University School of Medicine, Washington DC 20057, USA., Kellar KJ; Drug Discovery Program and Georgetown University School of Medicine, Washington DC 20057, USA.
Publikováno v:
European journal of pharmacology [Eur J Pharmacol] 2019 Feb 15; Vol. 845, pp. 1-7. Date of Electronic Publication: 2018 Dec 07.
Autor:
Mukherjee A; Drug Discovery and Nanomedicine Research Program, CA-90404, USA.; Department of Translational Neurosciences and Neurotherapeutics, John Wayne Cancer Institute, Pacific Neuroscience Institute, Providence Saint John's Health Center, Santa Monica, CA-90404, USA., Waters AK; Drug Discovery and Nanomedicine Research Program, CA-90404, USA.; Department of Translational Neurosciences and Neurotherapeutics, John Wayne Cancer Institute, Pacific Neuroscience Institute, Providence Saint John's Health Center, Santa Monica, CA-90404, USA., Babic I; Department of Translational Neurosciences and Neurotherapeutics, John Wayne Cancer Institute, Pacific Neuroscience Institute, Providence Saint John's Health Center, Santa Monica, CA-90404, USA., Nurmemmedov E; Department of Translational Neurosciences and Neurotherapeutics, John Wayne Cancer Institute, Pacific Neuroscience Institute, Providence Saint John's Health Center, Santa Monica, CA-90404, USA., Glassy MC; University of California San Diego, Moores Cancer Center, La Jolla, CA, USA.; Nascent Biotech, Inc., San Diego, CA, USA., Kesari S; Department of Translational Neurosciences and Neurotherapeutics, John Wayne Cancer Institute, Pacific Neuroscience Institute, Providence Saint John's Health Center, Santa Monica, CA-90404, USA., Yenugonda VM; Drug Discovery and Nanomedicine Research Program, CA-90404, USA.; Department of Translational Neurosciences and Neurotherapeutics, John Wayne Cancer Institute, Pacific Neuroscience Institute, Providence Saint John's Health Center, Santa Monica, CA-90404, USA.
Publikováno v:
Human antibodies [Hum Antibodies] 2019; Vol. 27 (1), pp. 53-62.
Autor:
Babic I; John Wayne Cancer Institute & Pacific Neuroscience Institute at Providence Saint John's Health Center, Santa Monica, CA 90404, USA., Yenugonda VM; John Wayne Cancer Institute & Pacific Neuroscience Institute at Providence Saint John's Health Center, Santa Monica, CA 90404, USA., Kesari S; John Wayne Cancer Institute & Pacific Neuroscience Institute at Providence Saint John's Health Center, Santa Monica, CA 90404, USA., Nurmemmedov E; John Wayne Cancer Institute & Pacific Neuroscience Institute at Providence Saint John's Health Center, Santa Monica, CA 90404, USA.
Publikováno v:
Future medicinal chemistry [Future Med Chem] 2018 Jun 01; Vol. 10 (12), pp. 1399-1403. Date of Electronic Publication: 2018 May 21.
Autor:
Babic I; Department of Translational Neurosciences and Neurotherapeutics, Pacific Neuroscience Institute, John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA.; Department of Translational Neurosciences and Neurotherapeutics, Pacific Neuroscience Institute, John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA., Nurmemmedov E; Department of Translational Neurosciences and Neurotherapeutics, Pacific Neuroscience Institute, John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA.; Department of Translational Neurosciences and Neurotherapeutics, Pacific Neuroscience Institute, John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA., Yenugonda VM; Department of Translational Neurosciences and Neurotherapeutics, Pacific Neuroscience Institute, John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA., Juarez T; Department of Translational Neurosciences and Neurotherapeutics, Pacific Neuroscience Institute, John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA., Nomura N; Department of Translational Neurosciences and Neurotherapeutics, Pacific Neuroscience Institute, John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA., Pingle SC; AbbVie, Chicago, CA, USA., Glassy MC; University of California San Diego, Moores Cancer Center, La Jolla, CA, USA.; Nascent Biotech, Inc., San Diego, CA, USA., Kesari S; Department of Translational Neurosciences and Neurotherapeutics, Pacific Neuroscience Institute, John Wayne Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA.
Publikováno v:
Human antibodies [Hum Antibodies] 2018 Feb 05; Vol. 26 (2), pp. 95-101.